Difference between revisions of "Oral contraceptive pill"
Jump to navigation
Jump to search
(nl update) |
(No difference)
|
Revision as of 02:05, 10 August 2012
The oral contraceptive pill, abbreviated OCP, is a widely used form of birth control that may result in distinctive histomorphologic changes.
General
Contraindications
- Acute or chronic liver disease (e.g. Wilson's disease).
- Bad migraines (with focal neurological signs).
- Bleed per vagina - undiagnosed.
- Cancer (endometrial, breast).
- Cardiovascular disease.
- Cardiovascular disease risk factors.
- Smoking >35 years.
- Uncontrolled BP.
- DVT.
- Suspected pregnancy.
Advantages of use
- Acne reduced, Anemia reduced.
- Benign breast disease reduced.
- Cancer reduced (ovary, endometrium).
- Dysmenorrhea Sx better.
- Endometriosis Sx better.
- Pregnancy prevention.
Bengin histomorphologic changes
Associated pathology
See also
References
- ↑ 1.0 1.1 Yeung, J.C.; Leonard, Blair J. N. (2005). The Toronto Notes 2005 - Review for the MCCQE and Comprehensive Medical Reference (2005 ed.). The Toronto Notes Inc. for Medical Students Inc.. pp. FM44. ISBN 978-0968592854.
- ↑ 2.0 2.1 Shiau, Carolyn; Toren, Andrew (2006). Toronto Notes 2006: Comprehensive Medical Reference (Review for MCCQE 1 and USMLE Step 2) (22nd edition (2006) ed.). Toronto Notes for Medical Students, Inc.. pp. GY20. ISBN 978-0968592861.
- ↑ Zaino, RJ. (Mar 2000). "Glandular lesions of the uterine cervix.". Mod Pathol 13 (3): 261-74. doi:10.1038/modpathol.3880047. PMID 10757337.
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 221. ISBN 978-0781765275.
- ↑ Rooks, JB.; Ory, HW.; Ishak, KG.; Strauss, LT.; Greenspan, JR.; Hill, AP.; Tyler, CW. (Aug 1979). "Epidemiology of hepatocellular adenoma. The role of oral contraceptive use.". JAMA 242 (7): 644-8. PMID 221698.